Evidence map›Paper›PMID 42243663›Full record

Observational studyBMC medical research methodology2026

Dynamic prediction of adverse outcomes in discharged COPD patients using patient-reported outcomes.

Jie Jin, Hangzhi He, Xiaojuan Hu, Shuping Xie, Xiangli Lu, Hui Zhao, Yanbo Zhang

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jie JinDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, Shanxi Province, China.
Hangzhi HeDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, Shanxi Province, China.
Xiaojuan HuDepartment of Medical Information Technology, Shanxi Medical University, Taiyuan, 030001, Shanxi Province, China.
Shuping XieDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, Shanxi Province, China.
Xiangli LuDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, Shanxi Province, China.
Hui ZhaoDepartment of Respiratory and Critical Care Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi Province, China. hui_zhao@sxmu.edu.cn.
Yanbo ZhangDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, Shanxi Province, China. sxmuzyb@126.com.

Funding

Higher education ten billion project of shanxi provincial department of education BY-ZB-2024007National Natural Science Foundation of China 82173631
6 · The paper itself

Abstract

backgroundTo develop dynamic prediction models based on longitudinal patient-reported outcomes (PROs) and evaluate the time-varying risk of adverse outcomes after hospital discharge in patients with chronic obstructive pulmonary disease (COPD), thereby improving the accuracy of risk prediction.

methodsHospitalized COPD patients who met the inclusion and exclusion criteria from five hospitals in Shanxi Province between December 2020 and April 2022 were included. The occurrence of readmission or death within three years after discharge was defined as the adverse outcome. PROs measured repeatedly during follow-up were treated as time-varying predictors. Three dynamic prediction approaches were constructed and compared: the Joint Latent Class Model (JLCM), Shared Random-Effects Model (SREM), and Landmark model. Model performance was evaluated and compared using the time-dependent area under the receiver operating characteristic curve (AUC), Brier score, and calibration curves. In addition, individual-level trajectories of PRO scores and their corresponding dynamic risk predictions were illustrated.

resultsA total of 344 COPD patients were included, among whom 111 patients (32.27%) experienced adverse outcomes during follow-up. Model comparison demonstrated that the SREM model consistently achieved higher AUC values and lower Brier scores across all landmark time points, and its calibration curves were close to the ideal diagonal line, indicating the best predictive performance. In the survival submodel, the association parameter for PRO scores was statistically significant (P < 0.001). Each one-unit increase in PRO score was associated with a 4.3% reduction in the risk of adverse outcomes (HR = 0.957, 95% CI: 0.933-0.980). In addition, educational level, procalcitonin, and C-reactive protein levels were significantly associated with the risk of adverse outcomes. In the longitudinal submodel, dyspnea severity (mMRC grade) was significantly negatively associated with PRO scores.

conclusionsLongitudinal PRO data effectively capture the dynamic changes in health status among COPD patients and can serve as important time-varying predictors for adverse outcomes. Among the three dynamic prediction approaches evaluated, the SREM model demonstrated the best predictive performance. These findings provide a scientific basis for risk stratification and individualized management strategies in COPD patients after hospital discharge. CLINICAL

trial registrationThe study was registered with the Chinese Clinical Trial Registry (Registration number: ChiCTR2200064900;Date of Registration:2022-10-21).

Indexed as

Patient DischargePatient Reported Outcome MeasuresPulmonary Disease, Chronic ObstructiveAgedChinaFemaleHumansMaleMiddle AgedPatient ReadmissionPrediction AlgorithmsRisk AssessmentROC CurveAdverse outcomesChronic obstructive pulmonary diseaseDynamic predictionJoint modelingPatient-reported outcomes

Identifiers

PMID42243663
PMCPMC13465670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.